Personalized medicine and drug hypersensitivities

被引:0
|
作者
Chiriac, A. M. [1 ,2 ]
机构
[1] Ctr Hosp Univ Montpellier, Dept Pneumol & Addictol, Praticien Hosp, Unite Explorat Allergies, Montpellier, France
[2] Univ Montpellier, IDESP INSERM, Montpellier, France
来源
REVUE FRANCAISE D ALLERGOLOGIE | 2020年 / 60卷 / 08期
关键词
Drug allergy; Machine learning; Personalized medicine; Quality of life; Risk stratification; ALLERGY; PHOLCODINE; CHILDREN; TESTS;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Personalized medicine is supposed to tailor actions of prevention and treatments to individual patient data. Personalized medicine is a challenge in the drug allergy/hypersensitivity field. If most interventions in drug allergy work-up have long been quite empirical (the patients being therefore tested more or less in the same way), the last decade has brought to light a bulk of data ensuing better risk stratification of patients. Therefore, changes occur in all fields of the so-called 6P medicine: personalized, preventive, predictive, based on proofs, participative and taking into account the patient's medical pathway. This paper addresses some of these changes, in order to bring to light recent progress in drug allergy work-up. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [31] Drug discovery and personalized medicine based on the functional genomics
    Katsuma, S
    Tsujimoto, G
    SEIKAGAKU, 2002, 74 (12): : 1441 - 1451
  • [32] CURRENT STATUS AND PERSPECTIVE OF PERSONALIZED MEDICINE IN DRUG DEVELOPMENT
    Nagumo, Akira
    DRUG METABOLISM REVIEWS, 2015, 47 : 27 - 28
  • [33] Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
    Garraway, Levi A.
    Jaenne, Pasi A.
    CANCER DISCOVERY, 2012, 2 (03) : 214 - 226
  • [34] Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine
    Ho, Dean
    Wang, Chung-Huei Katherine
    Chow, Edward Kai-Hua
    SCIENCE ADVANCES, 2015, 1 (07):
  • [35] Therapeutic Drug Monitoring as a Component of Personalized Medicine: Applications in Pediatric Drug Development
    Momper, J. D.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (02) : 138 - 140
  • [36] Optimising migraine treatment: from drug-drug interactions to personalized medicine
    Leda Marina Pomes
    Martina Guglielmetti
    Enrico Bertamino
    Maurizio Simmaco
    Marina Borro
    Paolo Martelletti
    The Journal of Headache and Pain, 2019, 20
  • [37] Optimising migraine treatment: from drug-drug interactions to personalized medicine
    Pomes, Leda Marina
    Guglielmetti, Martina
    Bertamino, Enrico
    Simmaco, Maurizio
    Borro, Marina
    Martelletti, Paolo
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
  • [38] CYP dependent drug interactions in polypharmacy: a personalized medicine approach
    Wozniak, J.
    Radermacher, J. C.
    Just, K.
    Stingl, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S27 - S27
  • [39] Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine
    Yang, Yujia
    Kong, Yajie
    Cui, Jinlei
    Hou, Yu
    Gu, Zhanjing
    Ma, Cuiqing
    STEM CELL REVIEWS AND REPORTS, 2024, 20 (05) : 1213 - 1226
  • [40] How personalized medicine is changing the rules of drug life exclusivity
    Sullivan, CG
    PHARMACOGENOMICS, 2004, 5 (04) : 429 - 432